59 related articles for article (PubMed ID: 20842636)
1. Acute lymphoblastic leukemia in a patient with type 1 Gaucher disease developing 1 year after discontinuation of enzyme replacement therapy.
Ranade A; Selegean S; Sandhu G; Ghali V; Shah VP
Am J Hematol; 2010 Nov; 85(11):908-9. PubMed ID: 20842636
[No Abstract] [Full Text] [Related]
2. Acute lymphoblastic leukemia during enzyme replacement therapy in type 1 Gaucher's disease.
Bozdag SC; Topcuoglu P; Kuzu I; Arat M
Clin Adv Hematol Oncol; 2013 Apr; 11(4):251-2. PubMed ID: 23604243
[No Abstract] [Full Text] [Related]
3. Unusual severe development of common B lymphoblastic leukemia in Gaucher disease type I.
Castelli R; Cassinerio E; Iurlo A; Zanella A; Gianelli U; Cappellini MD
Am J Hematol; 2006 May; 81(5):383-4. PubMed ID: 16628727
[No Abstract] [Full Text] [Related]
4. Gaucher or pseudo-Gaucher? The challenge of several diseases colliding in a pediatric patient.
Cajaiba MM; Reyes-Múgica M
Hum Pathol; 2009 Apr; 40(4):594-8. PubMed ID: 19084264
[TBL] [Abstract][Full Text] [Related]
5. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
Charrow J; Dulisse B; Grabowski GA; Weinreb NJ
Clin Genet; 2007 Mar; 71(3):205-11. PubMed ID: 17309642
[TBL] [Abstract][Full Text] [Related]
6. Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy.
de Fost M; van Noesel CJ; Aerts JM; Maas M; Pöll RG; Hollak CE
Haematologica; 2008 Jul; 93(7):1119-20. PubMed ID: 18519519
[No Abstract] [Full Text] [Related]
7. Hematologic manifestations and leukemia in Gaucher's disease.
Ranade A; Chintapatla R; Varma M; Sandhu G
Clin Adv Hematol Oncol; 2013 Apr; 11(4):253-5. PubMed ID: 23604244
[No Abstract] [Full Text] [Related]
8. Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease.
Altarescu G; Schiffmann R; Parker CC; Moore DF; Kreps C; Brady RO; Barton NW
Blood Cells Mol Dis; 2000 Aug; 26(4):285-90. PubMed ID: 11042029
[TBL] [Abstract][Full Text] [Related]
9. Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy.
Burrow TA; Cohen MB; Bokulic R; Deutsch G; Choudhary A; Falcone RA; Grabowski GA
J Pediatr; 2007 Feb; 150(2):202-6. PubMed ID: 17236903
[TBL] [Abstract][Full Text] [Related]
10. Uveitis in Gaucher disease.
Dweck A; Rozenman J; Ronen S; Zimran A; Elstein D
Am J Ophthalmol; 2005 Jul; 140(1):146-7. PubMed ID: 16038664
[TBL] [Abstract][Full Text] [Related]
11. Hypothesis: Concordance of Gaucher disease and large granular lymphocytic leukemia has biological plausibility.
Ruchlemer R; Maayan H; Elstein D; Broide E; Reinus C; Zimran A
Blood Cells Mol Dis; 2014 Dec; 53(4):219-20. PubMed ID: 25053276
[No Abstract] [Full Text] [Related]
12. Varied autopsy findings in five treated patients with Gaucher disease and parkinsonism include the absence of Gaucher cells.
Monestime G; Borger DK; Kim J; Lopez G; Allgaeuer M; Jain D; Vortmeyer A; Wang HW; Sidransky E
Mol Genet Metab; 2016 May; 118(1):55-9. PubMed ID: 26992326
[TBL] [Abstract][Full Text] [Related]
13. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
Pastores GM
Curr Opin Investig Drugs; 2010 Apr; 11(4):472-8. PubMed ID: 20336596
[TBL] [Abstract][Full Text] [Related]
14. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy.
Kauli R; Zaizov R; Lazar L; Pertzelan A; Laron Z; Galatzer A; Phillip M; Yaniv Y; Cohen IJ
Isr Med Assoc J; 2000 Feb; 2(2):158-63. PubMed ID: 10804944
[TBL] [Abstract][Full Text] [Related]
15. [French results of enzyme replacement therapy in Gaucher's disease].
Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
[TBL] [Abstract][Full Text] [Related]
16. [Gaucher disease type I diagnosed at 63 years old presenting with thrombocytopenia].
Kawahara S; Kato A; Oshimi K; Ida H
Rinsho Ketsueki; 2008 May; 49(5):335-9. PubMed ID: 18572811
[TBL] [Abstract][Full Text] [Related]
17. Treatment for LSDs: no longer just enzyme replacement therapy for Gaucher disease. Foreword.
Cohen IJ; Baris H; Mistry PK
Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():58. PubMed ID: 24380122
[No Abstract] [Full Text] [Related]
18. A case of Waldenström macroglobulinemia terminating in acute lymphoblastic leukemia.
Angelopoulos N; Camerone G; Guzzini F; Polli N
Haematologica; 1989; 74(3):309-12. PubMed ID: 2511104
[TBL] [Abstract][Full Text] [Related]
19. Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study.
Biegstraaten M; Mengel E; Maródi L; Petakov M; Niederau C; Giraldo P; Hughes D; Mrsic M; Mehta A; Hollak CE; van Schaik IN
Brain; 2010 Oct; 133(10):2909-19. PubMed ID: 20693542
[TBL] [Abstract][Full Text] [Related]
20. A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease.
Di Rocco M; Giona F; Carubbi F; Linari S; Minichilli F; Brady RO; Mariani G; Cappellini MD
Haematologica; 2008 Aug; 93(8):1211-8. PubMed ID: 18603565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
